跳至主要内容
临床试验/ACTRN12616000721404
ACTRN12616000721404尚未招募未知

Deprescribing anticholinergic and sedative medicines: A Feasibility Trial (DEFEAT-polypharmacy) in residential aged care facilities

Professor Steve Duffull, Dean of the Pharmacy school0 个研究点目标入组 150 人开始时间: 2016年6月1日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
150

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
65 Years 至 o limit(—)
性别
All

入选标准

  • 1.Aged 65 years or older
  • 2.A drug burden index (DBI) of 0.5 or greater
  • 3.Taking at least one anticholinergic medication from the reference anticholinergic list published by Salahudeen et al. or one sedative medicine as listed by Hilmer et al.

排除标准

  • 1.Limited life expectancy: resident is receiving palliative care or their life expectancy is 3 months or less, based on Holmes life expectancy calculator
  • 2.Residents admitted for hospice care (short-duration of stay of less than 4 weeks)
  • 3.Severe dementia: residents’ with a score on the Mini-mental State Examination test (MMSE) < 10
  • 4.Resident’s not prescribed any anticholinergic medicines.

研究者

发起方
Professor Steve Duffull, Dean of the Pharmacy school

相似试验

Deprescribing anticholinergic and sedative... | 临床试验